REDHILL BIOPHARMA LTD-SP ADR (RDHL)
US7574683014 - ADR
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 23.92M | -71.67M | -97.74M | -76.17M | -42.30M | |||
| Depreciation Amortization | 1.99M | 8.16M | 18.15M | 8.75M | 1.22M | |||
| Change In Working Capital | -15.62M | 8.01M | -1.15M | 8.42M | -2.34M | |||
| Interest Paid | 367.00K | 8.18M | 11.28M | 6.65M | 250.00K | |||
| Other non cash items | -46.11M | 26.32M | 15.70M | 10.43M | 2.68M | |||
| OPERATING CASH FLOW | -35.82M | -29.19M | -65.05M | -48.58M | -40.75M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -11.00K | -200.00K | -120.00K | -53.77M | -200.00K | |||
| Other Investing Activity | 15.00K | 8.50M | -8.03M | 18.13M | 5.37M | |||
| INVESTING CASH FLOW | 4.00K | 8.30M | -8.14M | -35.65M | 5.16M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -1.18M | -1.48M | -1.68M | 76.45M | -800.00K | |||
| Stock Issued/Repurchased | 13.96M | 23.81M | 82.54M | 23.92M | 36.31M | |||
| Other Financing Activity | 8.65M | -10.88M | -7.40M | -16.00M | 0.00 | |||
| FINANCING CASH FLOW | 21.44M | 11.45M | 73.46M | 84.37M | 35.51M | |||
| Exchange Rate Effect | -22.00K | -80.00K | -100.00K | 130.00K | 90.00K | |||
| CHANGE IN CASH | -14.40M | -9.52M | 170.00K | 270.00K | 10.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -35.82M | -29.19M | -65.05M | -48.58M | -40.75M | |||
| Capital Expenditure | -11.00K | -200.00K | -120.00K | -53.77M | -200.00K | |||
| FREE CASH FLOW | -35.83M | -29.39M | -65.17M | -102.35M | -40.95M | |||
All data in USD